¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
¸ðüžÆÀÇÇР/   ºÎÀÎÁ¾¾çÇР /   »ý½Ä³»ºÐºñÇР /   ÀϹݺÎÀΰúÇÐ
Æ÷½ºÅÍ : ¸ðüžÆÀÇÇÐ - ÀϽà : 2016³â 9¿ù 23ÀÏ(±Ý) ~ 2016³â 9¿ù 24ÀÏ(Åä)
- Àå¼Ò : EXHIBITION HALL B[1F]
(08:00~17:00)
1-OB0108:00~08:00 °íÁöÇý
¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú
Amniopatch procedures in preterm premature rupture of membranes: a single-center experience
2-OB0208:00~08:00 °ûµ¿¿í
Fetal crown–rump length and biparietal diameter between 11 + 0 and 13 + 6 weeks¡¯ gestation in a Korean population; conceived after in-vitro fertilization
3-OB0308:00~08:00 ±è±¤ÁØ
Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú
External cephalic version performed at out patient department with minimal preparations
4-OB0408:00~08:00 ±è´ÙÈñ
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Placental angiogenic factors : Useful factor for prediction of preeclampsia abut not of small for gestational
5-OB0508:00~08:00 ±è¹Î¾Æ
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
The pregnancy outcomes in women with inflammatory bowel disease: a systemic review and meta- analysis
6-OB0608:00~08:00 ±èÀ¯¹Î
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Antepartum antibiotic exposure in preterm pregnancy and antimicrobial resistance in neonatal early onset sepsis
7-OB0708:00~08:00 ±èÀ±È­
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Assessment of maternal cerebrovascular Doppler indices in pregnancies complicated by preeclampsia
8-OB0808:00~08:00 ±èÀÇÇõ
±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø »êºÎÀΰú
Elective labor induction at 39 and 40 or more weeks: maternal and neonatal benefits and risks
9-OB0908:00~08:00 ±èÁ¤¼÷
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Gender prevalence in Gestational and immune thrombocytopenia ; the preliminary study for immune response during pregnancy
10-OB1008:00~08:00 ¼­Èñ°æ
¼øõÇâÀÇ´ë õ¾Èº´¿ø »êºÎÀΰú
Adverse obstetric outcomes with endometriosis: meta-analyses
11-OB1108:00~08:00 ¼ÕÁö³ª
À»ÁöÀÇ´ë À»Áöº´¿ø »êºÎÀΰú
Effects of Corticotropin-Releasing Hormone On Intracellular Ca2+ Concentration In Oxytocin Stimulated Human Term Pregnant Myometrium
12-OB1208:00~08:00 ½ÅÀçÀº
°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø »êºÎÀΰú
The relationship between parity and metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Examination Survey 2010-2012
13-OB1308:00~08:00 ¾ç¼±Çý
ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø »êºÎÀΰú
Predictive value of maternal C-reactive protein at admission for latency period in preterm premature rupture of the membranes patients
14-OB1408:00~08:00 ¿À°ü¿µ
À»Áö´ëÇб³º´¿ø »êºÎÀΰú
Quantification of 5 Lactobacillus species, Gardnella vaginalis and Atopobium vaginae in vaginal microbiota of pregnant Korean women with Bacterial Vaginosis.
15-OB1508:00~08:00 À§Áö¼±
°¡Å縯ÀÇ´ë ¿©Àǵµ¼º¸ðº´¿ø »êºÎÀΰú
Adverse neonatal outcomes following nuchal cords of term pregnancy in vaginal delivery.
16-OB1608:00~08:00 À¯Å¸®
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
ÀӽŠÃʱâ chlamydia trachomatis °¨¿°
17-OB1708:00~08:00 À±°¡¿µ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
The role of Oxytocin and Oxytocin Receptor in Human Placenta according to Gestational age
18-OB1808:00~08:00 À±Ç×±¸
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Á¦¿ÕÀý°³ ¼ö¼ú ½Ã »ç¿ëÇÏ´Â Àç·á¿¡ µû¸¥ â»ó ºÀÇÕ¹ý °£ÀÇ ÀüÇâÀû ºñ±³ ¿¬±¸
19-OB1908:00~08:00 À̾ƿµ
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
PORE-SIZE DEPENDENT NATURAL HEALING OF RUPTURED AMNIOTIC MEMBRANE
20-OB2008:00~08:00 ÀÌÁö¼±
°æºÏ´ëÇб³º´¿ø »êºÎÀΰú
Difference of vitamin D level between first and third trimester and its relation to adverse pregnancy outcomes.
21-OB2108:00~08:00 ÀÌÁö¿¬
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Risk factors for massive postpartum bleeding in pregnancies with incomplete placenta previa located on the posterior uterine wall
22-OB2208:00~08:00 ÀÌÁö¿ø
ÇѸ²ÀÇ´ë °­µ¿¼º½Éº´¿ø »êºÎÀΰú
Impact of caffeine on the expression of hormonal receptors in trophoblast cell lines
23-OB2308:00~08:00 ÀÌÈñÁß
°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú
Influence of oral dydrogesterone and vaginal progesterone on threatened abortion: a systematic review and meta-analysis
24-OB2408:00~08:00 ÀÓµµÈ­
ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú
Association between the increasing incidence of placenta previa and IVF treatment in nulliparous women222
25-OB2508:00~08:00 Àå½Å¾Æ
ÀÎÇÏ´ëÇб³º´¿ø »êºÎÀΰú
Elevated serum cathepsin B concentration in pregnant women is associated with pre-eclampsia.
26-OB2608:00~08:00 ÀåÄ®¸®ÇýÁø
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Clinical Significance of abnormal vaginal colonization in patients presented with bulging membranes.
27-OB2708:00~08:00 Àü¼ö¿¬
°æºÏ´ëÇб³º´¿ø »êºÎÀΰú
Evaluation of the effectiveness of quantitative fetal fibronectin testing as a predictor of preterm birth among symptomatic preterm labor women
28-OB2808:00~08:00 Á¤À±Áö
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Comparison of severe and non-severe essential chronic hypertension during pregnancy: a ten year experience of a tertiary care center
29-OB2908:00~08:00 Á¤ÀºÁ¤
ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú
Antenatal magnesium sulfate for both short-term tocolysis and fetal neuroprotection in premature rupture of the membranes remote from term
30-OB3008:00~08:00 Á¶¹ÌÇö
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
The association between umbilical cord characteristics in antepartum ultrasonography, increased intrapartum cesarean section and adverse perinatal outcome.
31-OB3108:00~08:00 Á¶¹Î°æ
¿ï»êÀÇ´ë °­¸ª¾Æ»êº´¿ø »êºÎÀΰú
Dexamethasone versus betamethasone:comparison of antenatal corticosteroids on neonatal outcome in preterm newborn
32-OB3208:00~08:00 ÁÖÀº¿í
°­µ¿°æÈñ´ëÇб³º´¿ø »êºÎÀΰú
The reduction of the rate of uterine fundal pressure maneuvers by an inflatable obstetric belt in nulliparous women: A preliminary study
33-OB3308:00~08:00 ÃÖÇüÀº
ÀÎÇÏ´ëÇб³º´¿ø »êºÎÀΰú
Significance of Cathepsin B and D levels in pregnancy
ÀϹݿ¬Á¦ : ¸ðüžÆÀÇÇÐ - ÀϽà : 2016³â 9¿ù 23ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ A[3F]
OB01-OB05 (08:20~09:10) ÁÂÀå : ¿À¹ÎÁ¤(°í·ÁÀÇ´ë)
OB0108:20~08:30 À̹̿µ
¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú
Fetoscopic laser coagulation in twin-to-twin transfusion syndrome: A single center experience with over 100 cases
OB0208:30~08:40 Á¤¿µ¹Ì
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
½Öžƿ¡¼­ °èÅ뺰 ¼±Ãµ ±âÇüÀÇ ÀÏÄ¡¿¡ °üÇÑ ¿¬±¸
OB0308:40~08:50 ±è´ÙÇö
ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú
The prevalence of Group B Streptococcus (GBS) colonization in pregnant women using selective culture media
OB0408:50~09:00 ¹Ú¼ö¿¬
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
The differences of microbiota composition in vaginal fluid between term and preterm delivered women
OB0509:00~09:10 ÀåÁö¾Ö
¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú
Dickkopf-related protein 3 in cervicovaginal fluid as a novel non-invasive marker for intra-amniotic infection and/or inflammation in preterm labor or preterm premature rupture of membranes
OB06-OB10 (09:10~10:00) ÁÂÀå : ±è¿µÁÖ(ÀÌÈ­ÀÇ´ë)
OB0609:10~09:20 ±ÇÀÚ¿µ
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
placental TAM receptor plays a critical role in the maintenance of pregnancy by regulating TLR mediated immune response
OB0709:20~09:30 ÇÑÀ¯Á¤
Genome-wide gene expression analysis in the fetal trisomy 21 placenta
OB0809:30~09:40 Á¤¿ë¿í
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Analysis of the cell-free amniotic fluid transcriptome expressed during the euploid mid- trimester of pregnancy.
OB0909:40~09:50 ½ÉÀçÀ±
¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú
Efficacy and safety of ferric carboxymaltose versus ferrous sulfate with iron deficiency anemia during pregnancy: Subgroup analysis of Korean women
OB1009:50~10:00 ¹®Á¾È£
Àü³²´ëÇб³º´¿ø »êºÎÀΰú
The efficacy of 3rd generation cephalosporin plus metronidazole versus 3rd generation cephalosporin plus clarithromycin in perinatal outcomes for women with preterm premature rupture of membranes
OB11-OB15 (10:30~11:20) ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë)
OB1110:30~10:40 ±è¿µ¸®
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Comparisons of obstetrical outcomes among vaginal, intramuscular progesterone treatment and conservative management for the prevention of preterm birth in twin pregnancies with a short cervix
OB1210:40~10:50 ÀÌÁö¿¬
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Do reduced twin pregnancies require additional antenatal care after 20 weeks of gestation?
OB1310:50~11:00 Á¤ÁöÀº
Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú
Comparison of effectiveness of progesterone and cervical cerclage for the prevention of preterm birth in twin pregnancy
OB1411:00~11:10 ¾È±âÈÆ
°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú
A novel animal model for cervix excision-associated spontaneous preterm birth
OB1511:10~11:20 ÀÌ°æ³ë
ÇѸ²ÀÇ´ë °­³²¼º½Éº´¿ø »êºÎÀΰú
History-indicated cerclage : Indication, Perioperative outcome, operative complications and new algorithm
OB16-OB20 (11:20~12:10) ÁÂÀå : ¾çÁ¤ÀÎ(¾ÆÁÖÀÇ´ë)
OB1611:20~11:30 ½ÉÀ翵
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
Is Preeclampsia Itself a Risk Factor for the Development of Metabolic Syndrome in the Postpartum Period?
OB1711:30~11:40 ±è¹Î¾Æ
¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
The value of CRP/ albumin ratio in prediction of preeclampsia and its severity
OB1811:40~11:50 ÀÌ¿µÁÖ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Expression and regulation of sex steroid receptors in the placenta and its correlation with preeclampsia
OB1911:50~12:00 ³ëÁØÈ£
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Differences in maternal and neonatal clinical characteristics between Gram-positive and Gram-negative early onset neonatal sepsis delivered at preterm
OB2012:00~12:10 ÀÌ¿¹Èç
°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú
Pregnancy and neonatal outcomes in Group B Streptococcus agalactiae (GBS) infection during pregnancy
OB21-OB24 (12:10~12:50) ÁÂÀå : Á¤¿µÁÖ(ÀüºÏÀÇ´ë)
OB2112:10~12:20 ¼­Àº¼®
°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú
Perinatal outcomes in women with systemic lupus erythematosus
OB2212:20~12:30 ³²Áö³ª
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
Obstetric outcomes associated with sonographically identified large uterine fibroids
OB2312:30~12:40 Ãß°æÀÚ
´ë±¸°¡Å縯´ëÇб³º´¿ø »êºÎÀΰú
Uterine polyp and pregnancy outcome
OB2412:40~12:50 À§Á¤ÇÏ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
À¯»êÀÇ ±â¿Õ·ÂÀÌ Æó°æ±â ÀÌÈÄ ÀÚ»ì »ç°í ¹× ¿ì¿ïÁõÀÇ À¯º´À²¿¡ ¹ÌÄ¡´Â ¿µÇâ - ±¹¹Î °Ç°­ ¿µ¾ç Á¶»ç ÀÚ·á ±â¹Ý ¿¬±¸
OB25-OB28 (14:00~14:40) ÁÂÀå : ÃÖ¼ºÁø(¿¬¼¼¿øÁÖÀÇ´ë)
OB2514:00~14:10 À̽¹Ì
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Á¦¿ÕÀý°³¼ú ¿¹Á¤ ÀӽŠÁÖ¼ö¿¡ µû¸¥ ÀÀ±ÞÁ¦¿ÕÀý°³¼ú ¹× ¸ðü ÇÕº´ÁõÀÇ À§Çè
OB2614:10~14:20 ±è¼¼·¡
¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø »êºÎÀΰú
The risk of cesarean section after trial of labor in low risk pregnancies according to maternal body characteristics
OB2714:20~14:30 ȲÁö¿µ
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Outcomes of subsequent deliveries after Modified B Lynch sutures for uterine atony during cesarean section
OB2814:30~14:40 ÀÌ°¡À»
ÀüºÏ´ëÇб³º´¿ø »êºÎÀΰú
The effect of combined hemostatic techniques during cesarean section in placenta previa; preliminary study
OB29-OB32 (14:40~15:20) ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë)
OB2914:40~14:50 °ûµ¿¿í
Relationship between fetal crown–rump length at 11 to 14 weeks¡¯ gestation and pregnancy outcomes
OB3014:50~15:00 ¹ÚÁ¤¿¬
¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú
¼³ÇÏ Misoprostol Á¤À» »ç¿ëÇÑ ÀӽŠ1ºÐ±â À¯»êÀÇ ¾à¹°Àû Ä¡·áÀÇ ¾ÈÀü¼º°ú È¿°ú, ±×¸®°í ¼º°øÀûÀÎ ¾à¹°Àû Ä¡·áÀÇ °ü·Ã ÀÎÀÚ¿¡ ´ëÇÏ¿©
OB3115:00~15:10 ±è¿¬Èñ
°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú
The Most Commonly Reported Medication in Adverse Drug Reactions among women with obstetric condition in South Korea
OB3215:10~15:20 ±è½Å¿µ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Prevalence of low bone mineral density and associated risk factors in Korean puerperal women